Literature DB >> 5137586

Antimicrobial activity of neomycin C against Staphylococcus epidermidis.

J H Robertson, R Baas, R L Yeager, K Tsuji.   

Abstract

In vitro studies indicate that neomycin C is 50% as active as neomycin B against Staphylococcus epidermidis (ATCC 12228).

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5137586      PMCID: PMC376505          DOI: 10.1128/am.22.6.1164-1165.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  7 in total

1.  INFLUENCE OF CHEMICAL AND PHYSICAL FACTORS ON BIOLOGICAL RESPONSES TO NEOMYCINS B AND C.

Authors:  W T SOKOLSKI; C G CHIDESTER; D G KAISER
Journal:  J Pharm Sci       Date:  1964-07       Impact factor: 3.534

2.  Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms.

Authors:  S A Waksman; H A Lechevalier
Journal:  Science       Date:  1949-03-25       Impact factor: 47.728

3.  GLC assay method for neomycin in petrolatum-based ointments.

Authors:  B Van Giessen; K Tsuji
Journal:  J Pharm Sci       Date:  1971-07       Impact factor: 3.534

4.  Neomycins D, E and F: identity with paromamine, paromomycin I and paromomycin II.

Authors:  E J Hessler; H K Jahnke; J H Robertson; K Tsuji; K J Rinehart; W T Shier
Journal:  J Antibiot (Tokyo)       Date:  1970-09       Impact factor: 2.649

5.  Gas-liquid chromatographic determination of neomycins B and C.

Authors:  K Tsuji; J H Robertson
Journal:  Anal Chem       Date:  1969-08       Impact factor: 6.986

6.  Comparative study of responses to neomycins B and C by microbiological and gas-liquid chromatographic assay methods.

Authors:  K Tsuji; J H Robertson; R Baas; D J McInnis
Journal:  Appl Microbiol       Date:  1969-09
  7 in total
  1 in total

1.  Consistency evaluation between matrix components ratio and microbiological potency of tylosin major components.

Authors:  Khadijeh Hamidian; Mohsen Amini; Nasrin Samadi
Journal:  Daru       Date:  2018-10-25       Impact factor: 3.117

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.